The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prothrombin Complex Concentrate(PCC) Market Research Report 2024
Synopsis
Mainly used to treat congenital and acquired coagulation factor II, VII, IX, and X deficiencies (alone or in combination) including: coagulation factor IX deficiency (hemophilia B), and coagulation factor II, VII, X deficiency overdose of anticoagulants, vitamin K deficiency; patients with hemorrhage caused by liver disease need to correct coagulation dysfunction; when disseminated intravascular coagulation (DIC) occurs, coagulation factors II, VII, IX, and X are consumed in large quantities, which can be used in heparin Application after chemotherapeutic; prothrombin time prolongation due to various reasons and intended for surgery, but may be ineffective for those with coagulation factor V deficiency; treatment of bleeding symptoms in patients with hemophilia A who have produced factor VIII preparations ; Reversal of coumarin anticoagulant-induced bleeding.
The global Prothrombin Complex Concentrate(PCC) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Prothrombin Complex Concentrate(PCC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prothrombin Complex Concentrate(PCC).
Report Scope
The Prothrombin Complex Concentrate(PCC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prothrombin Complex Concentrate(PCC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prothrombin Complex Concentrate(PCC) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Beijing Tiantan Biological Products
SHANGHAI RAAS
Biotest
Taibang Biologic Group
HUALAN BIOLOGICAL ENGINEERING
WEIGUANG BIOLOGICAL
Green Cross
BOHUI
Guangdong Shuanglin Biopharmaceutical
Jiangxi Boya Bio-Pharmaceutical
Segment by Type
100IU
200IU
300IU
400IU
1000IU
Segment by Application
Hopistial
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prothrombin Complex Concentrate(PCC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prothrombin Complex Concentrate(PCC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Mainly used to treat congenital and acquired coagulation factor II, VII, IX, and X deficiencies (alone or in combination) including: coagulation factor IX deficiency (hemophilia B), and coagulation factor II, VII, X deficiency overdose of anticoagulants, vitamin K deficiency; patients with hemorrhage caused by liver disease need to correct coagulation dysfunction; when disseminated intravascular coagulation (DIC) occurs, coagulation factors II, VII, IX, and X are consumed in large quantities, which can be used in heparin Application after chemotherapeutic; prothrombin time prolongation due to various reasons and intended for surgery, but may be ineffective for those with coagulation factor V deficiency; treatment of bleeding symptoms in patients with hemophilia A who have produced factor VIII preparations ; Reversal of coumarin anticoagulant-induced bleeding.
The global Prothrombin Complex Concentrate(PCC) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Prothrombin Complex Concentrate(PCC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prothrombin Complex Concentrate(PCC).
Report Scope
The Prothrombin Complex Concentrate(PCC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prothrombin Complex Concentrate(PCC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prothrombin Complex Concentrate(PCC) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Beijing Tiantan Biological Products
SHANGHAI RAAS
Biotest
Taibang Biologic Group
HUALAN BIOLOGICAL ENGINEERING
WEIGUANG BIOLOGICAL
Green Cross
BOHUI
Guangdong Shuanglin Biopharmaceutical
Jiangxi Boya Bio-Pharmaceutical
Segment by Type
100IU
200IU
300IU
400IU
1000IU
Segment by Application
Hopistial
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prothrombin Complex Concentrate(PCC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prothrombin Complex Concentrate(PCC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prothrombin Complex Concentrate(PCC) Market Overview
1.1 Product Overview and Scope of Prothrombin Complex Concentrate(PCC)
1.2 Prothrombin Complex Concentrate(PCC) Segment by Type
1.2.1 Global Prothrombin Complex Concentrate(PCC) Market Value Comparison by Type (2024-2030)
1.2.2 100IU
1.2.3 200IU
1.2.4 300IU
1.2.5 400IU
1.2.6 1000IU
1.3 Prothrombin Complex Concentrate(PCC) Segment by Application
1.3.1 Global Prothrombin Complex Concentrate(PCC) Market Value by Application: (2024-2030)
1.3.2 Hopistial
1.3.3 Clinic
1.3.4 Others
1.4 Global Prothrombin Complex Concentrate(PCC) Market Size Estimates and Forecasts
1.4.1 Global Prothrombin Complex Concentrate(PCC) Revenue 2019-2030
1.4.2 Global Prothrombin Complex Concentrate(PCC) Sales 2019-2030
1.4.3 Global Prothrombin Complex Concentrate(PCC) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prothrombin Complex Concentrate(PCC) Market Competition by Manufacturers
2.1 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prothrombin Complex Concentrate(PCC) Average Price by Manufacturers (2019-2024)
2.4 Global Prothrombin Complex Concentrate(PCC) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prothrombin Complex Concentrate(PCC), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prothrombin Complex Concentrate(PCC), Product Type & Application
2.7 Prothrombin Complex Concentrate(PCC) Market Competitive Situation and Trends
2.7.1 Prothrombin Complex Concentrate(PCC) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prothrombin Complex Concentrate(PCC) Players Market Share by Revenue
2.7.3 Global Prothrombin Complex Concentrate(PCC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prothrombin Complex Concentrate(PCC) Retrospective Market Scenario by Region
3.1 Global Prothrombin Complex Concentrate(PCC) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prothrombin Complex Concentrate(PCC) Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2019-2030
3.2.1 Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2019-2024
3.2.2 Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2025-2030
3.3 Global Prothrombin Complex Concentrate(PCC) Global Prothrombin Complex Concentrate(PCC) Revenue by Region: 2019-2030
3.3.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Region: 2019-2024
3.3.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Region: 2025-2030
3.4 North America Prothrombin Complex Concentrate(PCC) Market Facts & Figures by Country
3.4.1 North America Prothrombin Complex Concentrate(PCC) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prothrombin Complex Concentrate(PCC) Sales by Country (2019-2030)
3.4.3 North America Prothrombin Complex Concentrate(PCC) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prothrombin Complex Concentrate(PCC) Market Facts & Figures by Country
3.5.1 Europe Prothrombin Complex Concentrate(PCC) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2019-2030)
3.5.3 Europe Prothrombin Complex Concentrate(PCC) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prothrombin Complex Concentrate(PCC) Market Facts & Figures by Country
3.6.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Country (2019-2030)
3.6.3 Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prothrombin Complex Concentrate(PCC) Market Facts & Figures by Country
3.7.1 Latin America Prothrombin Complex Concentrate(PCC) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prothrombin Complex Concentrate(PCC) Sales by Country (2019-2030)
3.7.3 Latin America Prothrombin Complex Concentrate(PCC) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Facts & Figures by Country
3.8.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prothrombin Complex Concentrate(PCC) Sales by Type (2019-2030)
4.1.1 Global Prothrombin Complex Concentrate(PCC) Sales by Type (2019-2024)
4.1.2 Global Prothrombin Complex Concentrate(PCC) Sales by Type (2025-2030)
4.1.3 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2019-2030)
4.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2019-2030)
4.2.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2019-2024)
4.2.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2025-2030)
4.2.3 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2019-2030)
4.3 Global Prothrombin Complex Concentrate(PCC) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prothrombin Complex Concentrate(PCC) Sales by Application (2019-2030)
5.1.1 Global Prothrombin Complex Concentrate(PCC) Sales by Application (2019-2024)
5.1.2 Global Prothrombin Complex Concentrate(PCC) Sales by Application (2025-2030)
5.1.3 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2019-2030)
5.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2019-2030)
5.2.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2019-2024)
5.2.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2025-2030)
5.2.3 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2019-2030)
5.3 Global Prothrombin Complex Concentrate(PCC) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Prothrombin Complex Concentrate(PCC) Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Beijing Tiantan Biological Products
6.2.1 Beijing Tiantan Biological Products Corporation Information
6.2.2 Beijing Tiantan Biological Products Description and Business Overview
6.2.3 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product Portfolio
6.2.5 Beijing Tiantan Biological Products Recent Developments/Updates
6.3 SHANGHAI RAAS
6.3.1 SHANGHAI RAAS Corporation Information
6.3.2 SHANGHAI RAAS Description and Business Overview
6.3.3 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product Portfolio
6.3.5 SHANGHAI RAAS Recent Developments/Updates
6.4 Biotest
6.4.1 Biotest Corporation Information
6.4.2 Biotest Description and Business Overview
6.4.3 Biotest Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotest Prothrombin Complex Concentrate(PCC) Product Portfolio
6.4.5 Biotest Recent Developments/Updates
6.5 Taibang Biologic Group
6.5.1 Taibang Biologic Group Corporation Information
6.5.2 Taibang Biologic Group Description and Business Overview
6.5.3 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product Portfolio
6.5.5 Taibang Biologic Group Recent Developments/Updates
6.6 HUALAN BIOLOGICAL ENGINEERING
6.6.1 HUALAN BIOLOGICAL ENGINEERING Corporation Information
6.6.2 HUALAN BIOLOGICAL ENGINEERING Description and Business Overview
6.6.3 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product Portfolio
6.6.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments/Updates
6.7 WEIGUANG BIOLOGICAL
6.6.1 WEIGUANG BIOLOGICAL Corporation Information
6.6.2 WEIGUANG BIOLOGICAL Description and Business Overview
6.6.3 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product Portfolio
6.7.5 WEIGUANG BIOLOGICAL Recent Developments/Updates
6.8 Green Cross
6.8.1 Green Cross Corporation Information
6.8.2 Green Cross Description and Business Overview
6.8.3 Green Cross Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Green Cross Prothrombin Complex Concentrate(PCC) Product Portfolio
6.8.5 Green Cross Recent Developments/Updates
6.9 BOHUI
6.9.1 BOHUI Corporation Information
6.9.2 BOHUI Description and Business Overview
6.9.3 BOHUI Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BOHUI Prothrombin Complex Concentrate(PCC) Product Portfolio
6.9.5 BOHUI Recent Developments/Updates
6.10 Guangdong Shuanglin Biopharmaceutical
6.10.1 Guangdong Shuanglin Biopharmaceutical Corporation Information
6.10.2 Guangdong Shuanglin Biopharmaceutical Description and Business Overview
6.10.3 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
6.10.5 Guangdong Shuanglin Biopharmaceutical Recent Developments/Updates
6.11 Jiangxi Boya Bio-Pharmaceutical
6.11.1 Jiangxi Boya Bio-Pharmaceutical Corporation Information
6.11.2 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Description and Business Overview
6.11.3 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
6.11.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prothrombin Complex Concentrate(PCC) Industry Chain Analysis
7.2 Prothrombin Complex Concentrate(PCC) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prothrombin Complex Concentrate(PCC) Production Mode & Process
7.4 Prothrombin Complex Concentrate(PCC) Sales and Marketing
7.4.1 Prothrombin Complex Concentrate(PCC) Sales Channels
7.4.2 Prothrombin Complex Concentrate(PCC) Distributors
7.5 Prothrombin Complex Concentrate(PCC) Customers
8 Prothrombin Complex Concentrate(PCC) Market Dynamics
8.1 Prothrombin Complex Concentrate(PCC) Industry Trends
8.2 Prothrombin Complex Concentrate(PCC) Market Drivers
8.3 Prothrombin Complex Concentrate(PCC) Market Challenges
8.4 Prothrombin Complex Concentrate(PCC) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Prothrombin Complex Concentrate(PCC) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Prothrombin Complex Concentrate(PCC) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Prothrombin Complex Concentrate(PCC) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Prothrombin Complex Concentrate(PCC) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Prothrombin Complex Concentrate(PCC) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Prothrombin Complex Concentrate(PCC) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Prothrombin Complex Concentrate(PCC) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Prothrombin Complex Concentrate(PCC), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Prothrombin Complex Concentrate(PCC), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prothrombin Complex Concentrate(PCC), Product Type & Application
Table 12. Global Key Manufacturers of Prothrombin Complex Concentrate(PCC), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prothrombin Complex Concentrate(PCC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prothrombin Complex Concentrate(PCC) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prothrombin Complex Concentrate(PCC) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Prothrombin Complex Concentrate(PCC) Sales by Region (2019-2024) & (K Units)
Table 18. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Region (2019-2024)
Table 19. Global Prothrombin Complex Concentrate(PCC) Sales by Region (2025-2030) & (K Units)
Table 20. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Region (2025-2030)
Table 21. Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Region (2019-2024)
Table 23. Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Region (2025-2030)
Table 25. North America Prothrombin Complex Concentrate(PCC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Prothrombin Complex Concentrate(PCC) Sales by Country (2019-2024) & (K Units)
Table 27. North America Prothrombin Complex Concentrate(PCC) Sales by Country (2025-2030) & (K Units)
Table 28. North America Prothrombin Complex Concentrate(PCC) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Prothrombin Complex Concentrate(PCC) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Prothrombin Complex Concentrate(PCC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Prothrombin Complex Concentrate(PCC) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Prothrombin Complex Concentrate(PCC) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Prothrombin Complex Concentrate(PCC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Prothrombin Complex Concentrate(PCC) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Prothrombin Complex Concentrate(PCC) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Prothrombin Complex Concentrate(PCC) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Prothrombin Complex Concentrate(PCC) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Prothrombin Complex Concentrate(PCC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Prothrombin Complex Concentrate(PCC) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Prothrombin Complex Concentrate(PCC) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Prothrombin Complex Concentrate(PCC) Sales (K Units) by Type (2019-2024)
Table 51. Global Prothrombin Complex Concentrate(PCC) Sales (K Units) by Type (2025-2030)
Table 52. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2019-2024)
Table 53. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2025-2030)
Table 54. Global Prothrombin Complex Concentrate(PCC) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Prothrombin Complex Concentrate(PCC) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2019-2024)
Table 57. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2025-2030)
Table 58. Global Prothrombin Complex Concentrate(PCC) Price (US$/Unit) by Type (2019-2024)
Table 59. Global Prothrombin Complex Concentrate(PCC) Price (US$/Unit) by Type (2025-2030)
Table 60. Global Prothrombin Complex Concentrate(PCC) Sales (K Units) by Application (2019-2024)
Table 61. Global Prothrombin Complex Concentrate(PCC) Sales (K Units) by Application (2025-2030)
Table 62. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2019-2024)
Table 63. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2025-2030)
Table 64. Global Prothrombin Complex Concentrate(PCC) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Prothrombin Complex Concentrate(PCC) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2019-2024)
Table 67. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2025-2030)
Table 68. Global Prothrombin Complex Concentrate(PCC) Price (US$/Unit) by Application (2019-2024)
Table 69. Global Prothrombin Complex Concentrate(PCC) Price (US$/Unit) by Application (2025-2030)
Table 70. CSL Corporation Information
Table 71. CSL Description and Business Overview
Table 72. CSL Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. CSL Prothrombin Complex Concentrate(PCC) Product
Table 74. CSL Recent Developments/Updates
Table 75. Beijing Tiantan Biological Products Corporation Information
Table 76. Beijing Tiantan Biological Products Description and Business Overview
Table 77. Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product
Table 79. Beijing Tiantan Biological Products Recent Developments/Updates
Table 80. SHANGHAI RAAS Corporation Information
Table 81. SHANGHAI RAAS Description and Business Overview
Table 82. SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product
Table 84. SHANGHAI RAAS Recent Developments/Updates
Table 85. Biotest Corporation Information
Table 86. Biotest Description and Business Overview
Table 87. Biotest Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Biotest Prothrombin Complex Concentrate(PCC) Product
Table 89. Biotest Recent Developments/Updates
Table 90. Taibang Biologic Group Corporation Information
Table 91. Taibang Biologic Group Description and Business Overview
Table 92. Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product
Table 94. Taibang Biologic Group Recent Developments/Updates
Table 95. HUALAN BIOLOGICAL ENGINEERING Corporation Information
Table 96. HUALAN BIOLOGICAL ENGINEERING Description and Business Overview
Table 97. HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product
Table 99. HUALAN BIOLOGICAL ENGINEERING Recent Developments/Updates
Table 100. WEIGUANG BIOLOGICAL Corporation Information
Table 101. WEIGUANG BIOLOGICAL Description and Business Overview
Table 102. WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product
Table 104. WEIGUANG BIOLOGICAL Recent Developments/Updates
Table 105. Green Cross Corporation Information
Table 106. Green Cross Description and Business Overview
Table 107. Green Cross Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Green Cross Prothrombin Complex Concentrate(PCC) Product
Table 109. Green Cross Recent Developments/Updates
Table 110. BOHUI Corporation Information
Table 111. BOHUI Description and Business Overview
Table 112. BOHUI Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. BOHUI Prothrombin Complex Concentrate(PCC) Product
Table 114. BOHUI Recent Developments/Updates
Table 115. Guangdong Shuanglin Biopharmaceutical Corporation Information
Table 116. Guangdong Shuanglin Biopharmaceutical Description and Business Overview
Table 117. Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product
Table 119. Guangdong Shuanglin Biopharmaceutical Recent Developments/Updates
Table 120. Jiangxi Boya Bio-Pharmaceutical Corporation Information
Table 121. Jiangxi Boya Bio-Pharmaceutical Description and Business Overview
Table 122. Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product
Table 124. Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Prothrombin Complex Concentrate(PCC) Distributors List
Table 128. Prothrombin Complex Concentrate(PCC) Customers List
Table 129. Prothrombin Complex Concentrate(PCC) Market Trends
Table 130. Prothrombin Complex Concentrate(PCC) Market Drivers
Table 131. Prothrombin Complex Concentrate(PCC) Market Challenges
Table 132. Prothrombin Complex Concentrate(PCC) Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prothrombin Complex Concentrate(PCC)
Figure 2. Global Prothrombin Complex Concentrate(PCC) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Prothrombin Complex Concentrate(PCC) Market Share by Type in 2023 & 2030
Figure 4. 100IU Product Picture
Figure 5. 200IU Product Picture
Figure 6. 300IU Product Picture
Figure 7. 400IU Product Picture
Figure 8. 1000IU Product Picture
Figure 9. Global Prothrombin Complex Concentrate(PCC) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Prothrombin Complex Concentrate(PCC) Market Share by Application in 2023 & 2030
Figure 11. Hopistial
Figure 12. Clinic
Figure 13. Others
Figure 14. Global Prothrombin Complex Concentrate(PCC) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Prothrombin Complex Concentrate(PCC) Market Size (2019-2030) & (US$ Million)
Figure 16. Global Prothrombin Complex Concentrate(PCC) Sales (2019-2030) & (K Units)
Figure 17. Global Prothrombin Complex Concentrate(PCC) Average Price (US$/Unit) & (2019-2030)
Figure 18. Prothrombin Complex Concentrate(PCC) Report Years Considered
Figure 19. Prothrombin Complex Concentrate(PCC) Sales Share by Manufacturers in 2023
Figure 20. Global Prothrombin Complex Concentrate(PCC) Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Prothrombin Complex Concentrate(PCC) Players: Market Share by Revenue in 2023
Figure 22. Prothrombin Complex Concentrate(PCC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Prothrombin Complex Concentrate(PCC) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Prothrombin Complex Concentrate(PCC) Sales Market Share by Country (2019-2030)
Figure 25. North America Prothrombin Complex Concentrate(PCC) Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Prothrombin Complex Concentrate(PCC) Sales Market Share by Country (2019-2030)
Figure 29. Europe Prothrombin Complex Concentrate(PCC) Revenue Market Share by Country (2019-2030)
Figure 30. Germany Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue Market Share by Region (2019-2030)
Figure 37. China Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Prothrombin Complex Concentrate(PCC) Sales Market Share by Country (2019-2030)
Figure 48. Latin America Prothrombin Complex Concentrate(PCC) Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Prothrombin Complex Concentrate(PCC) Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Prothrombin Complex Concentrate(PCC) Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Prothrombin Complex Concentrate(PCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Prothrombin Complex Concentrate(PCC) by Type (2019-2030)
Figure 58. Global Revenue Market Share of Prothrombin Complex Concentrate(PCC) by Type (2019-2030)
Figure 59. Global Prothrombin Complex Concentrate(PCC) Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Prothrombin Complex Concentrate(PCC) by Application (2019-2030)
Figure 61. Global Revenue Market Share of Prothrombin Complex Concentrate(PCC) by Application (2019-2030)
Figure 62. Global Prothrombin Complex Concentrate(PCC) Price (US$/Unit) by Application (2019-2030)
Figure 63. Prothrombin Complex Concentrate(PCC) Value Chain
Figure 64. Prothrombin Complex Concentrate(PCC) Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
